XML 114 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Derivatives (Tables)
 3 Months Ended
Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location
The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company’s derivatives, excluding embedded derivatives, held at:
 
 
 
 
March 31, 2015
 
December 31, 2014
 
 
Primary Underlying Risk Exposure
 
Gross
Notional
Amount
 
Estimated Fair Value
 
Gross
Notional
Amount
 
Estimated Fair Value
 
 
Assets
 
Liabilities
 
Assets
 
Liabilities
 
 
 
 
(In millions)
Derivatives Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
 
Fair value hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
Interest rate
 
$
5,975

 
$
2,296

 
$
22

 
$
6,044

 
$
2,064

 
$
21

Foreign currency swaps
 
Foreign currency exchange rate
 
2,699

 
77

 
354

 
2,708

 
65

 
100

Foreign currency forwards
 
Foreign currency exchange rate
 
2,735

 
—

 
251

 
2,335

 
—

 
291

Subtotal
 
 
 
11,409

 
2,373

 
627

 
11,087

 
2,129

 
412

Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
Interest rate
 
2,927

 
666

 
—

 
2,560

 
528

 
—

Interest rate forwards
 
Interest rate
 
200

 
70

 
—

 
225

 
63

 
—

Foreign currency swaps
 
Foreign currency exchange rate
 
19,897

 
1,139

 
1,508

 
18,325

 
563

 
930

Subtotal
 
 
 
23,024

 
1,875

 
1,508

 
21,110

 
1,154

 
930

Foreign operations hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency forwards
 
Foreign currency exchange rate
 
4,306

 
101

 
11

 
4,097

 
295

 
11

Currency options
 
Foreign currency exchange rate
 
8,233

 
385

 
8

 
6,419

 
415

 
—

Subtotal
 
 
 
12,539

 
486

 
19

 
10,516

 
710

 
11

Total qualifying hedges
 
46,972

 
4,734

 
2,154

 
42,713

 
3,993

 
1,353

Derivatives Not Designated or Not Qualifying as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
Interest rate
 
91,545

 
5,353

 
2,465

 
93,266

 
4,570

 
2,051

Interest rate floors
 
Interest rate
 
34,155

 
464

 
172

 
55,645

 
440

 
199

Interest rate caps
 
Interest rate
 
52,763

 
90

 
1

 
49,128

 
145

 
1

Interest rate futures
 
Interest rate
 
3,557

 
9

 
6

 
2,707

 
4

 
9

Interest rate options
 
Interest rate
 
35,261

 
1,666

 
27

 
48,078

 
1,241

 
75

Synthetic GICs
 
Interest rate
 
4,262

 
—

 
—

 
4,298

 
—

 
—

Foreign currency swaps
 
Foreign currency exchange rate
 
11,627

 
855

 
432

 
11,041

 
447

 
385

Foreign currency forwards
 
Foreign currency exchange rate
 
12,191

 
235

 
387

 
13,206

 
127

 
791

Currency futures
 
Foreign currency exchange rate
 
1,242

 
1

 
2

 
522

 
2

 
—

Currency options
 
Foreign currency exchange rate
 
9,734

 
531

 
295

 
8,324

 
585

 
340

Credit default swaps — purchased
 
Credit
 
2,711

 
15

 
49

 
2,830

 
8

 
34

Credit default swaps — written
 
Credit
 
10,206

 
190

 
4

 
10,527

 
181

 
6

Equity futures
 
Equity market
 
6,248

 
34

 
7

 
6,073

 
65

 
2

Equity index options
 
Equity market
 
42,751

 
1,411

 
1,079

 
39,345

 
1,426

 
1,036

Equity variance swaps
 
Equity market
 
24,449

 
192

 
664

 
24,598

 
196

 
639

TRRs
 
Equity market
 
3,375

 
11

 
78

 
3,297

 
22

 
101

Total non-designated or non-qualifying derivatives
 
346,077

 
11,057

 
5,668

 
372,885

 
9,459

 
5,669

Total
 
 
 
$
393,049

 
$
15,791

 
$
7,822

 
$
415,598

 
$
13,452

 
$
7,022
Components of Net Derivatives Gains (Losses)
The components of net derivative gains (losses) were as follows:
 
Three Months 
 Ended 
 March 31,
 
2015
 
2014
 
(In millions)
Derivatives and hedging gains (losses) (1)
$
848

 
$
452

Embedded derivatives gains (losses)
(27
)
 
(109
)
Total net derivative gains (losses)
$
821

 
$
343

__________________
(1)
Includes foreign currency transaction gains (losses) on hedged items in cash flow and non-qualifying hedging relationships, which are not presented elsewhere in this note.
Earned Income On Derivatives And Income Statement Location
The following table presents earned income on derivatives:
 
Three Months 
 Ended 
 March 31,
 
2015
 
2014
 
(In millions)
Qualifying hedges:
 
 
 
Net investment income
$
58

 
$
33

Interest credited to policyholder account balances
2

 
32

Other expenses
(3
)
 
(1
)
Non-qualifying hedges:
 
 
 
Net investment income
(1
)
 
(1
)
Net derivative gains (losses)
261

 
219

Policyholder benefits and claims
4

 
(8
)
Total
$
321

 
$
274
Amount and location of gains (losses) recognized in income for derivatives that are not designated or qualifying as hedging instruments
The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or qualifying as hedging instruments:
 
Net
Derivative
Gains (Losses)
 
Net
Investment
Income (1)
 
Policyholder
Benefits and
Claims (2)
 
(In millions)
Three Months Ended March 31, 2015
 
 
 
 
 
Interest rate derivatives
$
552

 
$
—

 
$
11

Foreign currency exchange rate derivatives
669

 
—

 
—

Credit derivatives — purchased
(11
)
 
(1
)
 
—

Credit derivatives — written
3

 
1

 
—

Equity derivatives
(462
)
 
(4
)
 
(99
)
Total
$
751

 
$
(4
)
 
$
(88
)
Three Months Ended March 31, 2014
 
 
 
 
 
Interest rate derivatives
$
298

 
$
—

 
$
12

Foreign currency exchange rate derivatives
69

 
—

 
—

Credit derivatives — purchased
1

 
1

 
—

Credit derivatives — written
(9
)
 
—

 
—

Equity derivatives
(181
)
 
(6
)
 
(38
)
Total
$
178

 
$
(5
)
 
$
(26
)
__________________
(1)
Changes in estimated fair value related to economic hedges of equity method investments in joint ventures, derivatives held in relation to trading portfolios and derivatives held within contractholder-directed unit-linked investments.
(2)
Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.
Net derivatives gains (losses) recognized on fair value derivatives and the related hedged items
The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses):
Derivatives in Fair Value
Hedging Relationships
 
Hedged Items in Fair Value
Hedging Relationships
 
Net Derivative
Gains (Losses)
Recognized
for Derivatives
 
Net Derivative
Gains (Losses)
Recognized for
Hedged Items
 
Ineffectiveness
Recognized in
Net Derivative
Gains (Losses)
 
 
 
 
(In millions)
Three Months Ended March 31, 2015
 
 
Interest rate swaps:
 
Fixed maturity securities
 
$
(5
)
 
$
7

 
$
2

 
 
Policyholder liabilities (1)
 
197

 
(198
)
 
(1
)
Foreign currency swaps:
 
Foreign-denominated fixed maturity securities
 
10

 
(8
)
 
2

 
 
Foreign-denominated policyholder account balances (2)
 
(249
)
 
245

 
(4
)
Foreign currency forwards:
 
Foreign-denominated fixed maturity securities
 
(17
)
 
16

 
(1
)
Total
 
$
(64
)
 
$
62

 
$
(2
)
Three Months Ended March 31, 2014
 
 
 
 
 
 
Interest rate swaps:
 
Fixed maturity securities
 
$
1

 
$
1

 
$
2

 
 
Policyholder liabilities (1)
 
209

 
(204
)
 
5

Foreign currency swaps:
 
Foreign-denominated fixed maturity securities
 
(4
)
 
4

 
—

 
 
Foreign-denominated policyholder account balances (2)
 
(27
)
 
32

 
5

Foreign currency forwards:
 
Foreign-denominated fixed maturity securities
 
10

 
(9
)
 
1

Total
 
$
189

 
$
(176
)
 
$
13

__________________
(1)
Fixed rate liabilities reported in policyholder account balances or future policy benefits.
(2)
Fixed rate or floating rate liabilities.
Derivatives and Non-Derivative Hedging Instruments in Net Investment Hedging Relationships
The following table presents the effects of derivatives in net investment hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of equity:
Derivatives in Net Investment Hedging Relationships (1), (2)
 
Amount of Gains (Losses) Deferred in AOCI
(Effective Portion)
 
 
(In millions)
Three Months Ended March 31, 2015
 
 
Foreign currency forwards
 
$
111

Currency options
 
(41
)
Total
 
$
70

Three Months Ended March 31, 2014
 
 
Foreign currency forwards
 
$
(34
)
Currency options
 
(114
)
Total
 
$
(148
)

__________________
(1)
During both the three months ended March 31, 2015 and 2014, there were no sales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from AOCI into earnings.
(2)
There was no ineffectiveness recognized for the Company’s hedges of net investments in foreign operations. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.
Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:
 
 
March 31, 2015
 
December 31, 2014
Rating Agency Designation of Referenced
Credit Obligations (1)
 
Estimated
Fair Value
of Credit
Default
Swaps
 
Maximum
Amount of Future
Payments under
Credit Default
Swaps (2)
 
Weighted
Average
Years to
Maturity (3)
 
Estimated
Fair Value
of Credit
Default
Swaps
 
Maximum
Amount of Future
Payments under
Credit Default
Swaps (2)
 
Weighted
Average
Years to
Maturity (3)
 
 
(In millions)
 
 
 
(In millions)
 
 
Aaa/Aa/A
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps (corporate)
 
$
8

 
$
636

 
2.3

 
$
10

 
$
677

 
2.4

Credit default swaps referencing indices
 
7

 
1,500

 
2.7

 
10

 
1,700

 
2.6

Subtotal
 
15

 
2,136

 
2.6

 
20

 
2,377

 
2.6

Baa
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps (corporate)
 
23

 
1,555

 
2.6

 
23

 
1,591

 
2.8

Credit default swaps referencing indices
 
97

 
5,742

 
4.9

 
94

 
5,774

 
4.7

Subtotal
 
120

 
7,297

 
4.4

 
117

 
7,365

 
4.3

Ba
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps (corporate)
 
1

 
60

 
2.7

 
—

 
60

 
3.0

Credit default swaps referencing indices
 
—

 
100

 
1.8

 
(1
)
 
100

 
2.0

Subtotal
 
1

 
160

 
2.1

 
(1
)
 
160

 
2.4

B
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps (corporate)
 
—

 
—

 
—

 
—

 
—

 
—

Credit default swaps referencing indices
 
50

 
613

 
4.7

 
39

 
625

 
4.9

Subtotal
 
50

 
613

 
4.7

 
39

 
625

 
4.9

Total
 
$
186

 
$
10,206

 
4.0

 
$
175

 
$
10,527

 
3.9

__________________
(1)
The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.
(2)
Assumes the value of the referenced credit obligations is zero.
(3)
The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
 
 
March 31, 2015
 
December 31, 2014
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement (6)
 
Assets
 
Liabilities
 
Assets
 
Liabilities
 
 
(In millions)
Gross estimated fair value of derivatives:
 
 
 
 
 
 
 
 
OTC-bilateral (1)
 
$
14,441

 
$
6,600

 
$
12,256

 
$
6,017

OTC-cleared (1)
 
1,558

 
1,230

 
1,380

 
1,054

Exchange-traded
 
44

 
15

 
71

 
11

Total gross estimated fair value of derivatives (1)
 
16,043

 
7,845

 
13,707

 
7,082

Amounts offset on the consolidated balance sheets
 
—

 
—

 
—

 
—

Estimated fair value of derivatives presented on the consolidated balance sheets (1)
 
16,043

 
7,845

 
13,707

 
7,082

Gross amounts not offset on the consolidated balance sheets:
 
 
 
 
 
 
 
 
Gross estimated fair value of derivatives: (2)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(4,980
)
 
(4,980
)
 
(4,082
)
 
(4,082
)
OTC-cleared
 
(1,166
)
 
(1,166
)
 
(989
)
 
(989
)
Exchange-traded
 
(1
)
 
(1
)
 
(5
)
 
(5
)
Cash collateral: (3), (4)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(7,076
)
 
(111
)
 
(4,153
)
 
(133
)
OTC-cleared
 
(364
)
 
(62
)
 
(386
)
 
(62
)
Exchange-traded
 
—

 
(8
)
 
—

 
(4
)
Securities collateral: (5)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(2,063
)
 
(1,407
)
 
(3,768
)
 
(1,700
)
OTC-cleared
 
—

 
(2
)
 
—

 
(3
)
Exchange-traded
 
—

 
(6
)
 
—

 
(2
)
Net amount after application of master netting agreements and collateral
 
$
393

 
$
102

 
$
324

 
$
102

__________________
(1)
At March 31, 2015 and December 31, 2014, derivative assets include income or expense accruals reported in accrued investment income or in other liabilities of $252 million and $255 million, respectively, and derivative liabilities include income or expense accruals reported in accrued investment income or in other liabilities of $23 million and $60 million, respectively.
(2)
Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)
Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. In certain instances, cash collateral pledged to the Company as initial margin for OTC-bilateral derivatives is held in separate custodial accounts and is not recorded on the Company’s balance sheet because the account title is in the name of the counterparty (but segregated for the benefit of the Company). The amount of this off-balance sheet collateral was $327 million and $263 million at March 31, 2015 and December 31, 2014, respectively.
(4)
The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2015 and December 31, 2014, the Company received excess cash collateral of $259 million and $87 million (including $94 million and $36 million off-balance sheet cash collateral held in separate custodial accounts), respectively, and provided excess cash collateral of $240 million and $192 million, respectively, which is not included in the table above due to the foregoing limitation.
(5)
Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at March 31, 2015 none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At March 31, 2015 and December 31, 2014, the Company received excess securities collateral with an estimated fair value of $384 million and $395 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At March 31, 2015 and December 31, 2014, the Company provided excess securities collateral with an estimated fair value of $116 million and $117 million, respectively, for its OTC-bilateral derivatives, and $237 million and $199 million, respectively, for its OTC-cleared derivatives, and $212 million and $245 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
(6)
See Note 5 for information regarding the Company’s gross and net payables and receivables under repurchase agreement transactions.
Derivative Instruments, Gain (Loss) [Line Items]  
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location
The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of equity:
Derivatives in Cash Flow
Hedging Relationships
 
Amount of Gains
(Losses) Deferred in
AOCI on Derivatives
 
Amount and Location
of Gains (Losses)
Reclassified from
AOCI into Income (Loss)
 
Amount and Location
of Gains (Losses)
Recognized in Income
(Loss) on Derivatives
 
 
(Effective Portion)
 
(Effective Portion)
 
(Ineffective Portion)
 
 
 
 
Net Derivative
Gains (Losses)
 
Net Investment
Income
 
Other
Expenses
 
Net Derivative
Gains (Losses)
 
 
(In millions)
Three Months Ended March 31, 2015
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
$
174

 
$
5

 
$
3

 
$
—

 
$
3

Interest rate forwards
 
15

 
3

 
1

 
1

 
—

Foreign currency swaps
 
(2
)
 
(567
)
 
—

 
—

 
4

Credit forwards
 
—

 
—

 
—

 
—

 
—

Total
 
$
187

 
$
(559
)
 
$
4

 
$
1

 
$
7

Three Months Ended March 31, 2014
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
$
228

 
$
15

 
$
2

 
$
—

 
$
5

Interest rate forwards
 
41

 
—

 
1

 
—

 
1

Foreign currency swaps
 
52

 
36

 
(1
)
 
1

 
—

Credit forwards
 
—

 
—

 
—

 
—

 
—

Total
 
$
321

 
$
51

 
$
2

 
$
1

 
$
6
Schedule of Derivative Instruments
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that the Company would be required to provide if there was a one notch downgrade in the Company’s credit rating at the reporting date or if the Company’s credit rating sustained a downgrade to a level that triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table.
 
 
 
 
Estimated Fair Value of
Collateral Provided
 
Fair Value of Incremental
Collateral Provided Upon
 
 
Estimated
Fair Value of
Derivatives in 
Net Liability
Position (1)
 
Fixed Maturity
Securities
 
Cash
 
One Notch
Downgrade in 
the Company’s
Credit Rating
 
Downgrade in the Company’s
Credit Rating to a Level
that Triggers Full Overnight
Collateralization or Termination
of the Derivative Position
 
 
(In millions)
March 31, 2015
 
 
 
 
 
 
 
 
 
 
Derivatives subject to credit-contingent provisions
 
$
1,519

 
$
1,454

 
$
117

 
$
4

 
$
4

Derivatives not subject to credit-contingent provisions
 
91

 
68

 
2

 
—

 
—

Total
 
$
1,610

 
$
1,522

 
$
119

 
$
4

 
$
4

December 31, 2014
 
 
 
 
 
 
 
 
 
 
Derivatives subject to credit-contingent provisions
 
$
1,832

 
$
1,750

 
$
131

 
$
5

 
$
7

Derivatives not subject to credit-contingent provisions
 
84

 
65

 
2

 
—

 
—

Total
 
$
1,916

 
$
1,815

 
$
133

 
$
5

 
$
7

__________________
(1)
After taking into consideration the existence of netting agreements.
Embedded Derivative Financial Instruments [Member]  
Derivative Instruments, Gain (Loss) [Line Items]  
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location
The following table presents changes in estimated fair value related to embedded derivatives:
 
Three Months 
 Ended 
 March 31,
 
2015
 
2014
 
(In millions)
Net derivative gains (losses) (1)
$
(27
)
 
$
(109
)
Policyholder benefits and claims
$
24

 
$
15

__________________
(1)
The valuation of guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were $69 million and $43 million for the three months ended March 31, 2015 and 2014, respectively.
Schedule of Derivative Instruments
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
 
 
Balance Sheet Location
 
March 31, 2015
 
December 31, 2014
 
 
 
 
(In millions)
Net embedded derivatives within asset host contracts:
 
 
 
 
 
 
Ceded guaranteed minimum benefits
 
Premiums, reinsurance and other receivables
 
$
351

 
$
324

Funds withheld on assumed reinsurance
 
Other invested assets
 
56

 
53

Options embedded in debt or equity securities
 
Investments
 
(303
)
 
(217
)
Net embedded derivatives within asset host contracts
 
$
104

 
$
160

Net embedded derivatives within liability host contracts:
 
 
 
 
 
 
Direct guaranteed minimum benefits
 
Policyholder account balances and Future policy benefits
 
$
(830
)
 
$
(1,126
)
Assumed guaranteed minimum benefits
 
Policyholder account balances
 
868

 
973

Funds withheld on ceded reinsurance
 
Other liabilities
 
71

 
83

Other
 
Policyholder account balances
 
28

 
24

Net embedded derivatives within liability host contracts
 
$
137

 
$
(46
)